ROIVANT SCIENCES LTD's ticker is and the CUSIP is G76279101. A total of 79 filers reported holding ROIVANT SCIENCES LTD in Q3 2022. The put-call ratio across all filers is 0.31 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,993,190 | -8.5% | 598,732 | -21.1% | 0.27% | +3.0% |
| Q2 2023 | $7,646,436 | +66.4% | 758,575 | +21.8% | 0.26% | +65.6% |
| Q1 2023 | $4,594,626 | +3.5% | 622,578 | +12.1% | 0.16% | -5.3% |
| Q4 2022 | $4,439,356 | +172.7% | 555,614 | +9.9% | 0.17% | +148.5% |
| Q3 2022 | $1,628,000 | -20.9% | 505,577 | 0.0% | 0.07% | -12.8% |
| Q2 2022 | $2,058,000 | +28.7% | 505,577 | +56.2% | 0.08% | +59.2% |
| Q1 2022 | $1,599,000 | -51.0% | 323,643 | 0.0% | 0.05% | -46.2% |
| Q4 2021 | $3,262,000 | – | 323,643 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VI Management, LLC | 1,119,489 | $11,284,449 | 97.24% |
| QVT Financial LP | 122,541,536 | $1,235,218,683 | 67.65% |
| Patient Square Capital LP | 12,639,920 | $127,410,394 | 62.03% |
| Two Seas Capital LP | 7,909,591 | $79,728,677 | 17.43% |
| SB INVESTMENT ADVISERS (UK) LTD | 83,031,667 | $836,959,203 | 6.38% |
| Octagon Capital Advisors LP | 3,904,000 | $39,352,320 | 5.48% |
| Anchorage Capital Group, L.L.C. | 4,832,642 | $48,713,031 | 4.30% |
| VIKING GLOBAL INVESTORS LP | 75,238,700 | $758,406,096 | 3.10% |
| HSG Holding Ltd | 2,595,838 | $26,166,047 | 2.99% |
| Artia Global Partners LP | 824,363 | $8,309,579 | 2.86% |